Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...

Ovarian cancer is characterized by uncontrolled growth of cells in the ovaries. It can progress to another part of the body ...

Separate facts and misconceptions about ovarian cancer to help better prevent and manage the disease.

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...

Nancy Long was a gynecological nurse practitioner when she was diagnosed with ovarian cancer. Yet because the symptoms were so vague, she nearly ignored them. “I missed all the signs and symptoms of ...

Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities ...

A clear guide to ovarian cancer, symptoms, treatment, and early detection.

In this video, Rebecca Stone, MD, MS, discussed the year in review in ovarian cancer, including a deepening understanding of the role of PARP inhibitors and more. "Increasing understanding of the ...

Gemogenovatucel-T is a DNA-engineered, triple-function immunotherapy that utilizes a patient's autologous tumor cells as a source for the complete matrix of tumor-related clonal signals. Its mechanism ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...